Skip to main content
SSO 2026 Annual Meeting Main banner

Breast

Melanoma

Endocrine

Sarcoma

CME

Best Papers I

Friday, March 6, 2026
8:00 AM - 9:30 AM MST
Location:301A
CE: 1.5

Presentations:

  • 8:02 AM - 8:09 AM MST
    BP1. Neoadjuvant Pembrolizumab in Stage IIB/C Melanoma: Updated Clinical Outcomes and Translational Data from Phase 2 Trial NCT03757689

    Co-Author: Anthony Lee, BS – University of Pennsylvania

    Co-Author: Guanning Wang, PhD – University of Pennsylvania

    Co-Author: Sheryl Mitnick, MPH, BSN (she/her/hers) – University of Pennsylvania

    Co-Author: Phyllis Gimotty, PhD – Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania

    Co-Author: Gracia M. Vargas, MD – Hospital of the University of Pennsylvania

    Co-Author: Russell A. Simons, MD, MPH – Division of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania

    Co-Author: John T. Miura, MD – Division of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania

    Co-Author: Tara C. Mitchell, MD – Division of Hematology-Oncology, Hospital of the University of Pennsylvania

    Co-Author: Ravi K. Amaravadi, MD – Division of Hematology-Oncology, Hospital of the University of Pennsylvania

    Co-Author: Lynn M. Schuchter, MD – Division of Hematology-Oncology, Hospital of the University of Pennsylvania

    Co-Author: Xiaowei Xu, MD, PhD – Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania

    Co-Author: Michael A. Davies, MD, PhD – Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center

    Co-Author: Rodabe N. Amaria, MD – Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center

    Co-Author: Jason A. Chesney, MD, PhD – Division of Medical Oncology and Hematology, University of Louisville

    Co-Author: Roi Weiser, MD – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center

    Co-Author: Jeffrey E. Gershenwald, MD (he/him/his) – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center

    Co-Author: Kelly M. McMasters, MD, PhD (he/him/his) – Department of Surgery, University of Louisville

    Co-Author: Alexander C. Huang, MD – Division of Hematology-Oncology, Hospital of the University of Pennsylvania

    Co-Author: Giorgos C. Karakousis, MD (he/him/his) – Department of Surgery, University of Pennsylvania Health System

    Primary Presenter: M. Saad Farooq, MD, MSTR – Hospital of the University of Pennsylvania

  • 8:09 AM - 8:16 AM MST
    BP2. Adjuvant anti-PD-1 therapy in elderly patients with melanoma: an analysis of the Sentinel Lymph Node Working Group cohort

    Primary Presenter: Luke D. Rothermel, MD, MPH – University Hospitals Cleveland Medical Center

    Co-Author: Natalie N. Chakraborty, MD (she/her/hers) – University Hospitals Cleveland Medical Center

    Co-Author: Caitlyn N. Balsay-Patel, MD – Moffitt Cancer Center

    Co-Author: Michelle M. Dugan, MD – University of Florida

    Co-Author: John T. Vetto, MD, FACS, FSSO – Oregon Health & Science University

    Co-Author: J. Harrison Howard, MD, FACS – University of South Alabama

    Co-Author: Jukes P. Namm, MD, FACS, FSSO, HEC-C – Loma Linda University Health, Department of Surgery, Division of Surgical Oncology

    Co-Author: Roger Olofsson Bagge, MD, PhD – University of Gothenburg

    Co-Author: Tina J. Hieken, MD, FACS – Mayo Clinic -Rochester

    Co-Author: Shlomo Schneebaum, MD – Tel Aviv Sourasky Medical Center

    Co-Author: Mohammed Kashani-Sabet, MD – Sutter Health

    Co-Author: Barbara A. Pockaj, MD – Mayo Clinic

    Co-Author: Cristina O'Donoghue, MD, MPH (she/her/hers) – University of Chicago Pritzker School of Medicine

    Co-Author: Parker Olive, BS – University of South Florida

    Co-Author: Alexis Hernandez-Flores, BS – University of South Florida Morsani College of Medicine

    Co-Author: Heidi Kosiorek, MS – Mayo Clinic

    Co-Author: Giorgos C. Karakousis, MD (he/him/his) – Department of Surgery, University of Pennsylvania Health System

    Co-Author: Richard L. White, Jr., MD, FACS (he/him/his) – Atrium Health

    Co-Author: Stanley Leong, MD, MS, FACS (he/him/his) – Sutter Health

    Co-Author: Jonathan S. Zager, MD, FACS – Moffitt Cancer Center

  • 8:16 AM - 8:23 AM MST
    BP3. Loss of cDC1s Highlights Role of Virus-Specific CD8⁺ T Cells in T-VEC + αPD1 Response

    Co-Author: Joe Frost, DPhil – Memorial Sloan Kettering Cancer Center

    Co-Author: Fatima Salman, BS – Memorial Sloan Kettering Cancer Center/ Sloan Kettering Institute - Immunology

    Co-Author: Cristian Mantilla Rosa, MD (he/him/his) – Memorial Sloan Kettering Cancer Center

    Co-Author: Emma Andretta, BS – Sloan Kettering Institute

    Co-Author: Jian Hu, DPhil – Memorial Sloan Kettering Cancer Center

    Co-Author: Danielle Vaithilingam, MS – Memoral Sloan Kettering Cancer Center

    Co-Author: Xinjun Wang, PhD – Memorial Sloan Kettering Cancer Center

    Co-Author: Alexander Rudensky, PhD – Memorial Sloan Kettering Cancer Center/ Sloan Kettering Institute

    Co-Author: Charlotte E. Ariyan, MD, PhD – Memorial Sloan Kettering Cancer Center

    Primary Presenter: Aparna Vancheswaran, MD – Memorial Sloan Kettering Cancer Center

  • 8:23 AM - 8:30 AM MST
    BP4. Dasatinib reverses myeloid derived suppressor cell (MDSC) inhibition of T-cell proliferation in a triple negative breast cancer model

    Co-Author: Himanshu Savardekar, PhD – Ohio State University

    Co-Author: Alvin Liu, n/a – Ohio State University

    Co-Author: Colin Angell, n/a – Ohio State University

    Co-Author: Emily Schwarz, PhD – Ohio State University

    Co-Author: Alex Abreo, n/a – Ohio State University

    Co-Author: William Carson, III, MD – Ohio State University

    Primary Presenter: Ian Garbarine, MD (he/him/his) – Ohio State University

  • 8:30 AM - 8:37 AM MST
    BP5. Borderline epithelial lesions of the breast and low-grade DCIS show similar rates of subsequent ipsilateral DCIS and invasive disease: a 10-year follow-up report

    Primary Presenter: Claire M. Eden, MD – Memorial Sloan Kettering Cancer Center

    Co-Author: Varadan Sevilimedu, MBBS, DrPH – Memorial Sloan Kettering Cancer Center

    Co-Author: Andrea V. Barrio, MD – Memorial Sloan Kettering Cancer Center

    Co-Author: Monica Morrow, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center

    Co-Author: Kimberly J. Van Zee, MD, MS – Memorial Sloan Kettering Cancer Center

    Primary Author: Daniel Choi, MD – Memorial Sloan Kettering Cancer Center

  • 8:37 AM - 8:44 AM MST
    BP6. Metastatic progression of pheochromocytoma and paraganglioma occurs via parallel evolution

    Co-Author: Bradley Wubbenhorst, MS – University of Pennsylvania

    Co-Author: Kurt D'Andrea, BS – University of Pennsylvania

    Co-Author: John Pluta, BS – University of Pennsylvania

    Co-Author: Wajid Amjad, BS – University of Pennsylvania

    Co-Author: Jake Shilan, MD – University of Pennsylvania

    Co-Author: Debbie L. Cohen, MD – University of Pennsylvania

    Co-Author: Bonita Weathers, MPH – University of Pennsylvania

    Co-Author: Bonita Bennett, RN – University of Pennsylvania

    Co-Author: Maria Bonanni, NP – University of Pennsylvania

    Co-Author: Kathleen Montone, MD – University of Pennsylvania

    Co-Author: Katharine Nathanson, MD – University of Pennsylvania

    Co-Author: Heather Wachtel, MD, MTR (she/her/hers) – University of Pennsylvania Health System

    Primary Presenter: Andrew Pregnall, MSc, MPhil (he/him/his) – University of Pennsylvania

  • 8:44 AM - 8:51 AM MST
    BP7. Expression of Neuronal Axon Guidance Proteins may be Uniquely Associated with Metastasis in Pheochromocytoma and Paraganglioma

    Co-Author: Spencer Mehdizadeh, BS – University of Rochester

    Co-Author: Nabeel Khan, n/a – University of Toronto

    Co-Author: Christine Miller, n/a – University of Rochester

    Co-Author: Luke Cybulski, MD – University of Rochester

    Co-Author: Chelsea Marin, MD – University of Rochester

    Primary Presenter: Alessandra L. Moore, MD FACS FSSO – University of Rochester

  • 8:51 AM - 8:58 AM MST
    BP8. Single-cell RNA sequencing reveals that imatinib alters tumor-associated macrophages in GIST

    Co-Author: Juan Esteban Perez, MD – Perelman School of Medicine

    Co-Author: Shan Zeng, MD, PhD – Perelman School of Medicine

    Co-Author: Taylor E. Hartlein, MD (she/her/hers) – University of Pennsylvania

    Co-Author: Iulia Barbur, MD – Hospital of the University of Pennsylvania

    Co-Author: Ferdinando Rossi, PhD – Perelman School of Medicine

    Co-Author: Kevin Do, BS – Hospital of the University of Pennsylvania

    Co-Author: Jonathan H. Sussman, PhD – Perelman School of Medicine

    Co-Author: Ronald P. DeMatteo, MD – University of Pennsylvania

    Primary Presenter: Montana T. Morris, MD – University of Pennsylvania

  • 8:58 AM - 9:05 AM MST
    BP9. Non-Genetic Mechanisms of Fractional Resistance to Abemaciclib in Dedifferentiated Liposarcoma

    Primary Presenter: Lauryn E. Bailey, BS – UNC Chapel Hill School of Medicine, Department of Genetics

    Primary Author: Sam Wolff, PhD (he/him/his) – UNC Chapel Hill School of Medicine, Department of Genetics

    Co-Author: Tarek M. Zikry, PhD – UNC Chapel Hill School of Data Science and Society

    Co-Author: Garrett A. Sessions, n/a – UNC Chapel Hill School of Medicine, Department of Cell Biology and Physiology

    Co-Author: Austin Whitman, n/a – UNC Chapel Hill School of Medicine, Department of Surgery

    Co-Author: Elizaveta K. Titerina, MD (she/her/hers) – Department of Surgery, Division of Surgical Oncology, James Cancer Center, The Ohio State University

    Co-Author: Hayden Raish, n/a – Department of Surgery, Division of Surgical Oncology, James Cancer Center, The Ohio State University

    Co-Author: Joal D. Beane, MD – Department of Surgery, The Ohio State University Wexner Medical Center

    Co-Author: Jeremy Purvis, PhD – UNC Chapel Hill School of Medicine, Department of Genetics

    Primary Author: Philip M. Spanheimer, MD (he/him/his) – University of North Carolina, Department of Surgery

    Co-Author: Lauryn E. Bailey, BS – UNC Chapel Hill School of Medicine, Department of Genetics

  • 9:05 AM - 9:12 AM MST
    BP10. Single cell and Spatial Transcriptomic Profiling of Uterine Leiomyosarcomas Reveals Molecular Programs with Distinct Therapeutic Vulnerabilities

    Primary Author: Maria Korah, MD – Stanford University

    Co-Author: James P. Agolia, MD – Stanford University

    Co-Author: Biren Reddy, BA – Stanford University School of Medicine

    Co-Author: Renceh Flojo, BS – Stanford University

    Co-Author: Amanda Gonçalves, BS – Stanford University

    Co-Author: Lilin Wang, BS – University of Minnesota

    Co-Author: Rosyli F. Reveron-Thornton, MD, MS (she/her/hers) – Stanford University

    Co-Author: Chuner Guo, MD, PhD – Stanford University

    Co-Author: Beatrice J. Sun, MD, MS (she/her/hers) – Stanford University School of Medicine

    Co-Author: Amanda R. Kirane, MD PhD (she/her/hers) – Stanford University

    Co-Author: George Poultsides, MD – Stanford University

    Co-Author: Deshka Foster, MD PhD (she/her/hers) – Stanford University

    Co-Author: R. Stephanie Huang, PhD – University of Minnesota

    Co-Author: Gregory Charville, MD, PhD – Stanford University

    Co-Author: Michael Longaker, MD – Stanford University

    Co-Author: Byrne Lee, MD (he/him/his) – Stanford University

    Co-Author: Daniel Delitto, MD PhD – Stanford University

    Primary Presenter: Maria Korah, MD – Stanford University

  • 9:12 AM - 9:19 AM MST
    BP11. Budget impact of implementing a financial navigation program for cancer patients in Nigeria

    Co-Author: Ciaran Kohli-Lynch, PhD – Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University

    Co-Author: Ricky Hill, PhD – Northwestern University

    Co-Author: Kristina M. Diaz, MSN RN CNL – Department of Surgery, Robert J. Havey, MD Institute for Global Health, Northwestern University Feinberg School of Medicine

    Co-Author: Funmilola O. Wuraola, MBBS FWACS ChM – Obafemi Awolowo University Teaching Hospitals Complex

    Co-Author: Chinenye Iwuji, BM BSc MSc PhD (she/her/hers) – Department of Oncology, Lakeshore Cancer Center

    Co-Author: Oge Ilegbune, MBBS – Lakeshore Cancer Center

    Co-Author: Chukumere Nwogu, MD, PhD – Lakeshore Cancer Center; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center

    Co-Author: Bindiya Chugani, MSc – Lakeshore Cancer Center

    Co-Author: Lisa Hirshchhorn, MD, MPH – Department of Medical Social Sciences and Robert Havey Institute for Global Health, Feinberg School of Medicine, Northwestern University

    Co-Author: Dan Sherman, MA, LPC – The NaVectis Group

    Co-Author: Clara Lambert, BBA, CPH – TailorMed

    Co-Author: Andrei Adin-Cristian, PhD – Department of Preventive Medicine, Division of Biostatistics and Informatics, Northwestern University, Feinberg School of Medicine

    Co-Author: T. Peter Kingham, MD – Memorial Sloan Kettering Cancer Center

    Co-Author: Ruohui Chen, PhD – Department of Preventive Medicine, Division of Biostatistics and Informatics, Northwestern University, Feinberg School of Medicine

    Co-Author: Juliet S. Lumati, MD MPH – Department of Surgery, Robert J. Havey, MD Institute for Global Health, Northwestern University Feinberg School of Medicine

    Primary Presenter: Segun Afolaranmi, MD, MSc – Mayo Clinic

  • 9:19 AM - 9:26 AM MST
    BP12. One Big Beautiful Bill (HR1) Impact on Medicaid Enrollee Cancer Screening & Outcomes

    Co-Author: Sarah Shubeck, MD, MS – University of Chicago

    Primary Presenter: Adrian Diaz, MD – University of Chicago